MedTrace Logo

Drug Cocktail Interaction Study of St. John's Wort Dry Extract Ze 117

NCT03482817 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-03-29

No results posted yet for this study

Summary

This Study evaluates the Effect of St. John's Wort dry Extract Ze 117 on Several Cytochrome P450 Enzymes and on Transporter P-Glycoprotein in Healthy Volunteers.

Conditions

  • Drug Interaction Study

Interventions

DRUG

Ze 117

Subjects will be hospitalized to receive a probe drug cocktail alone and in combination with Ze 117.

DRUG

Probe drug cocktail

Subjects will be hospitalized to receive a probe drug cocktail alone and in combination with Ze 117.

Sponsors & Collaborators

  • Max Zeller Soehne AG

    lead INDUSTRY

Principal Investigators

  • Michael Lissy · Neu-Ulm

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2018-05-17
Completion
2018-06-23

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482817 on ClinicalTrials.gov